Showing posts with label Diseconony of Scale. Show all posts
Showing posts with label Diseconony of Scale. Show all posts

Thursday, September 3, 2009

Pfizer agrees record fraud fine

This article is a good example to use as support for various important BaM topics –

a) An example of the dangers of poor marketing strategy. Pizer has been fined for off-label promoting – that is – for promoting its products for uses that had NOT been approved by its external regulator (the US Federal Drugs Agency)

b) An example of possible diseconomies of scale – Pizer is the worlds largest drug producer: as such the business hay have suffered communication problems in making sure that the ruling by the FDA clearly prevented the firm from promoting its products for non- approved usage

c) An example of effective contingency planning – Pizers share price has remained unaffected by this news because the company had already put aside money to cover any fines in its 4th quarter in 2008